Methods for enhancing angiogenesis in a mammal using hepatocyte growth
factor ("HGF") are provided. In the methods, HGF can be administered to
mammals suffering from, for instance, vascular insufficiency or arterial
occlusive disease. Articles of manufacture and kits containing HGF are
also provided.